Literature DB >> 22065464

Insomnia as predictor versus outcome of PTSD and depression among Iraq combat veterans.

Kathleen M Wright1, Thomas W Britt, Paul D Bliese, Amy B Adler, Dante Picchioni, Dewayne Moore.   

Abstract

OBJECTIVES: The study conducted a longitudinal assessment of insomnia as an antecedent versus consequence of posttraumatic stress disorder (PTSD) and depression symptoms among combat veterans.
DESIGN: Two postdeployment time points were used in combination with structural equation modeling to examine the relative strength of two possible directions of prediction: insomnia as a predictor of psychological symptoms, and psychological symptoms as a predictor of insomnia. Participants were active duty soldiers (N = 659) in a brigade combat team who were assessed 4 months after their return from a 12-month deployment to Iraq, and then again eight months later.
RESULTS: Although both insomnia and psychological symptoms were associated at both time periods and across time periods, insomnia at 4 months postdeployment was a significant predictor of change in depression and PTSD symptoms at 12 months postdeployment, whereas depression and PTSD symptoms at 4 months postdeployment were not significant predictors of change in insomnia at 12 months postdeployment.
CONCLUSIONS: Results support the role of insomnia in the development of additional psychological problems and highlight the clinical implications for combat veterans, to include the importance of longitudinal assessment and monitoring of sleep disturbances, and the need for early intervention.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 22065464     DOI: 10.1002/jclp.20845

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  82 in total

1.  Neural correlates of working memory performance in primary insomnia.

Authors:  Sean P A Drummond; Matthew Walker; Erin Almklov; Manuel Campos; Dane E Anderson; Laura D Straus
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

2.  Pre-deployment insomnia is associated with post-deployment post-traumatic stress disorder and suicidal ideation in US Army soldiers.

Authors:  Hohui E Wang; Laura Campbell-Sills; Ronald C Kessler; Xiaoying Sun; Steven G Heeringa; Matthew K Nock; Robert J Ursano; Sonia Jain; Murray B Stein
Journal:  Sleep       Date:  2019-02-01       Impact factor: 5.849

3.  Insomnia Symptoms Among Female Veterans: Prevalence, Risk Factors, and the Impact on Psychosocial Functioning and Health Care Utilization.

Authors:  Kimberly A Babson; Ava C Wong; Danielle Morabito; Rachel Kimerling
Journal:  J Clin Sleep Med       Date:  2018-06-15       Impact factor: 4.062

Review 4.  Piloting cognitive-behavioral therapy for insomnia integrated with prolonged exposure.

Authors:  Peter J Colvonen; Sean P A Drummond; Abigail C Angkaw; Sonya B Norman
Journal:  Psychol Trauma       Date:  2018-09-13

5.  Sleep disorders in combat-related PTSD.

Authors:  Scott G Williams; Jacob Collen; Nicholas Orr; Aaron B Holley; Christopher J Lettieri
Journal:  Sleep Breath       Date:  2014-04-22       Impact factor: 2.816

6.  Resilience and readiness through restorative sleep.

Authors:  Anne Germain
Journal:  Sleep       Date:  2015-02-01       Impact factor: 5.849

7.  Validation of the Pittsburgh Sleep Quality Index Addendum for posttraumatic stress disorder (PSQI-A) in U.S. male military veterans.

Authors:  Salvatore P Insana; Martica Hall; Daniel J Buysse; Anne Germain
Journal:  J Trauma Stress       Date:  2013-03-19

8.  Sound sleep, a crucial component of military medicine's armamentarium?

Authors:  Paul E Peppard; Kevin J Reichmuth
Journal:  Sleep       Date:  2013-01-01       Impact factor: 5.849

9.  The relationship between military occupation and diagnosed insomnia following combat deployment.

Authors:  Andrew J MacGregor; Rachel R Markwald; Amber L Dougherty; Gilbert Seda
Journal:  J Clin Sleep Med       Date:  2020-07-15       Impact factor: 4.062

Review 10.  Sleep disturbances as the hallmark of PTSD: where are we now?

Authors:  Anne Germain
Journal:  Am J Psychiatry       Date:  2013-04       Impact factor: 18.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.